Inflammasome-associated pyroptosis and tumor angiogenesis in prostate cancer

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 27

فایل این مقاله در 24 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-29-9_002

تاریخ نمایه سازی: 17 مهر 1405

چکیده مقاله:

Tumor angiogenesis in prostate cancer is increasingly recognized as a dynamic process shaped by inflammatory signaling, endothelial adaptation, and microenvironmental stress. However, the mechanistic contribution of inflammasome-associated pyroptosis to vascular remodeling remains insufficiently integrated, particularly in relation to functional vascular endpoints such as perfusion, permeability, and therapeutic delivery. This review critically evaluates current evidence linking inflammasome activation and pyroptotic signaling to angiogenic remodeling within prostate tumor microenvironments. Current mechanistic and translational studies addressing inflammasome signaling, gasdermin-associated membrane permeabilization, endothelial activation, cytokine amplification, and vascular remodeling were synthesized with emphasis on spatial heterogeneity, hypoxia-associated stress, and methodological limitations. Available evidence suggests that inflammasome-associated pathways may influence angiogenic remodeling through interleukin-۱-mediated endothelial activation, myeloid-cell inflammatory amplification, extracellular signaling, and context-dependent pyroptotic responses. Emerging findings further indicate that vascular consequences vary according to metabolic stress, compartment-specific signaling, and local inflammatory states. However, interpretation remains limited by reliance on static tissue measurements, bulk inflammatory analyses, and indirect vascular readouts that insufficiently distinguish inflammasome priming from terminal pyroptotic execution. Inflammasome-associated pyroptotic signaling may contribute to vascular remodeling in prostate cancer under defined biological conditions, although substantial mechanistic and translational uncertainties remain. Improved integration of spatial inflammatory profiling and functional vascular assessment may support more precise therapeutic targeting and clinically relevant vascular interpretation in heterogeneous prostate tumor microenvironments.

نویسندگان

- -

Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan

- -

College of Pharmacy, Alnoor University, Mosul, Iraq

- -

Department of Otorhinolaryngology, Samarkand State Medical University, Samarkand, Uzbekistan

- -

Department of Medical Fundamental Sciences, Termez University of Economics and Service, Termez, Uzbekistan

- -

Scientific-Practical Medical Center for Pediatric Oncology, Hematology and Immunology, Tashkent, Uzbekistan

- -

Department of Pharmacy, College of Pharmacy, The Islamic University, Najaf, Iraq

- -

University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India

- -

Center for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, ۱۴۰۴۰۱, Punjab, India

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Børretzen A, Reisæter LAR, Ringheim A, Gravdal K, Haukaas SA, ...
  • Liu X, Wang Z, Zhu H, Han Y, Ji Q. ...
  • Tóth A, Jeney V. Hypoxia-induced changes in endothelial cell phenotype ...
  • Arndt P, Boewe S, Brüggemann J, Garcia-Garcia B, Yakupov R, ...
  • Lee JD, Kumar A, Mathur T, Jain A. Vascular architecture-on-chip: ...
  • Liberale L, Duncker D, Hausenloy D, Kraler S, Bøtker H, ...
  • Erasha A, El-Gendy H, Aly A, Fernández-Ortiz M, Sayed R. ...
  • Shakerdi A, Finnegan E, Sheng YY, Vidovic K, Logan J, ...
  • Liu S, Zhang J. A comprehensive analysis of the relationship ...
  • Chen S, Deng B, Liu Y, Xie L, Xu J, ...
  • Colarusso C, Terlizzi M, Di Caprio S, Falanga A, D’Andria ...
  • Wang H, Li, Su W, Liu Y, Xie N, Liu ...
  • Ghoreifi A, Alshalalfa M, Davicioni E, Spratt DE, Karnes RJ, ...
  • Zhuo Z, Xie Y, Zou H, Tan B, Dong Q, ...
  • Jiang J, Yan Y, Yang C, Cai H. Immunogenic cell ...
  • Cheng X, Wang Y, Johnson B, You M. Mitochondria-targeted strategies ...
  • Xu X, Pang Y, Fan X. Mitochondria in oxidative stress, ...
  • Liang X, Weng J, You Z, Wang Y, Wen J, ...
  • Yang Q, Cui M, Wang J, Zhao Y, Yin W, ...
  • Deng X, Huang S. Microbiome-macrophage crosstalk in the tumor microenvironment: ...
  • Zhao F, Jiang X, Li Y, Huang T, Xiahou Z, ...
  • Benimam M, Meas-Yedid V, Mukherjee S, Frafjord A, Corthay A, ...
  • Erreni M, Fumagalli M, Marozzi M, Leone R, Parente R, ...
  • Chai Z, Zhou Y, Hossain S, Huynh K, Hajimirzaei S, ...
  • Paik S, Kim JK, Shin HJ, Park EJ, Kim IS, ...
  • Chen Z, Behrendt R, Wild L, Schlee M, Bode C. ...
  • Zou C, Jiang S, Li H, Zhao K, Cao D, ...
  • Alanazi A, Selim M, Liu F, Zhang D, Narayanan S, ...
  • Cheng H, Nan F, Ji N, Xiao, Zhang J, Liang ...
  • Song B, Guo W, He Y, Yao X, Sun J, ...
  • Lee C, Park YW, Park MH, Lee YJ, Rhee I. ...
  • Li Y, Guo B. GSDMD-mediated pyroptosis: Molecular mechanisms, diseases and ...
  • Shojaee F, Azadian E, Wong MX, Xiuquan, Rickard J, Pang ...
  • Zhang H, Zhao T, Gu J, Tang F, Zhu L. ...
  • Nguyen T, Kwon SJ, Hurh S, Kale A, Cho JM, ...
  • M Bader S, Scherer L, Schaefer J, Cooney JP, Mackiewicz ...
  • Schachter J, Guijarro A, Angosto-Bazarra D, Pinilla M, Hurtado-Navarro L, ...
  • Wang C, Dreyer B, Teran E, Ruan J. From pores ...
  • Broz P. Pyroptosis: Molecular mechanisms and roles in disease. Cell ...
  • Ren K, Farrell J, Li Y, Guo X, Xie R, ...
  • Zandonadi R, Ramos MC, Elias FTS, Guimarães N. Global insights ...
  • An YW, Li S, Huang X, Chen XS, Xu M, ...
  • Van Velthoven C, Gao Y, Kunst M, Lee C, McMillen ...
  • Zhou B, Abbott D. Gasdermins, executors of pyroptosis: A decade ...
  • Elkayam E, Gervais FG, Wu H, Crackower MA, Lieberman J. ...
  • Yang S, Qi Y, Chen Y, Kong H, Han B, ...
  • Zavoriti A, Miossec P. Understanding cardiovascular events with JAK inhibitors: ...
  • Jung JU, Stippec S, Cobb M. Activation of WNK۱ signaling ...
  • Xie H, Ji J, Liu Z, Lu N, Wei Y, ...
  • Ye F, Huang J, Cheng X, Chen SC, Huang F, ...
  • Zheng K, Wang S, Deng M, Luo Y, Li W, ...
  • Nishida A, Andoh A. The role of inflammation in cancer: ...
  • Rakib A, Mamun MA Al, Mandal M, Sinha P, Singh ...
  • Zhang J, Lv S, Peng X, Liu H, Guo J, ...
  • Guo Y, Liu Q, Yang J, Gao Y, Liu Y. ...
  • Wang WL, Shih YT, Wei S, Chiu J. Impacts of ...
  • Shi S, Ou X, Liu C, Wen H, Ke J. ...
  • Deng H, Rukhlenko O, Joshi D, Hu X, Junk P, ...
  • Mandalà M. Oxidative stress and inflammation in uterine–vascular adaptation during ...
  • Rannikko J, Turpin R, Boström P, Virtakoivu R, Harth C, ...
  • Sarapultsev A, Komelkova M, Lookin O, Khatsko S, Zhdanov A, ...
  • Petropoulos A, Stavropoulou E, Tsigalou C, Bezirtzoglou E. Microbiota gut–brain ...
  • Guan F, Wang R, Yi Z, Luo P, Liu W, ...
  • Mulyani AT, Khairinisa M, Khatib A, Chaerunisaa A. Understanding stunting: ...
  • Palley B, Martins JP, Bernardo H, Rossetti R. Integrating machine ...
  • Roka R, Figueiredo A, Vieira A, Cardoso C. A systematic ...
  • Wang Y, Guan QN, Zhang ZJ, Zhang YM. Interaction between ...
  • Alhumaydhi FA, Anwar S. Extracellular vesicles in cancer: Mechanistic insights ...
  • Cui C, Yang R, Chen H, Li D, Sun X, ...
  • Izadpanah R, Izadpanah A, Alt EU. Dual faces of angiogenesis: ...
  • Zhang J, Gao P, Chang WR, Song JY, An FY, ...
  • Dong Y, Li T, Fang B, Long D, Tian Y, ...
  • Clements A, Casillas A, Flores C, Liou H, Toth R, ...
  • Oyende Y, Taus L, Fatatis A. IL-۱β in neoplastic disease ...
  • Li H, Liu T, Shi X, Du H, Cai C, ...
  • Rossetto RZ, De Oliveira Maciel S, Cardoso A. Relationship between ...
  • Aram C, Barancheshmeh M, Alishvandi A, Khodabandehloo MH, Shirvani AH, ...
  • Kwon W, Joung JY. Precision targeting in metastatic prostate cancer: ...
  • Lu X, Sun Y, Zhang Z, Sun Z, Wang S, ...
  • Gu C, Wang D, Zhu S, Wang X, Tian X, ...
  • Boixareu C, Taha T, Venkadakrishnan V, De Bono J, Beltran ...
  • Liang C, Liu X, Yu J, Shi L, Wei W, ...
  • Kleandrova V, Cordeiro M, Speck-Planche A. In silico approach for ...
  • Abo-Alian A, Youssef M, Badr N. A data-driven approach to ...
  • Tanous O, Hosny N, Joseph S. Are we all post ...
  • Prakash C, Mahar R. Chemical Profiling and quality assessment of ...
  • Fazekas T, Miszczyk M, Giesen A, Kói T, Zattoni F, ...
  • Bastos D, Soares A, Schutz FAB, Cronemberger E, De Almeida ...
  • Muniz M, Sartor O, Orme J, Koch R, Scharf Z, ...
  • Huang X, Hu J. In silico discovery of novel androgen ...
  • Ibáñez C, Touris-Lores M, Montesa Á, López-Campos F, Ríos E, ...
  • James N, Rush H, Nankivell M, Sehjal J, Mangar S, ...
  • Galsky M, Autio K, Cabanski C, Wentzel K, Graff J, ...
  • Wang X, Jing J. Cancer immunotherapy in combination with radiotherapy ...
  • Rai V. Immune checkpoint inhibitor therapy for prostate cancer: Present ...
  • Zhang M, Liu C, Tu J, Tang M, Ashrafizadeh M, ...
  • Zhang L, Fu J, Liu X, Feng S, Leng YJ. ...
  • Pei X, Liu L, Han Y. Advances in human microbiome ...
  • Chen R, Zou J, Chen J, Zhong X, Kang R, ...
  • Sharma M, Waterston A, Randolph CJ, Stark LE, Gravano DM, ...
  • Chee YJ, Dalan R, Cheung C. The interplay between immunity, ...
  • Li J, Zhang L, Zhan Y, Han X, Deng C. ...
  • Herrick W, Tran HL, Tomaino F, Beall B, Govindharajulu J, ...
  • Xu X, Lv X, Zeng R, Huang Z, Huang Z, ...
  • Yang S, Guan Y, Zheng C, Xia X, Xiaosheng, Jiang ...
  • Hu Y, Qi E, Yun C, Li X, Liu F, ...
  • Yang X, Hong S, Yan T, Liu M, Liu M, ...
  • Kim J, Schanzer N, Singh RS, Zaman M, Garcia-Medina J, ...
  • Aghaee M, Ramirez AA, Alam Z, Ali R, Andrzejczuk M, ...
  • Wu J, Qian Y, Yang K, Zhang S, Zeng E, ...
  • Kushwaha R, Patel S, Yuvaraj K, Sharma P, Kumar A, ...
  • Jensen L, Guo Z, Sun X, Jing X, Yang Y, ...
  • Liu H, Wang S, Wang J, Guo X, Song Y, ...
  • Wawrzak-Pienkowska K, Pienkowski T, Tankiewicz-Kwedlo A, Ciborowski M, Kurek K, ...
  • Ciringione A, Rizzi F. Facing the challenge to mimic breast ...
  • Mohapatra R, Leist M, Von Aulock S, Hartung T. Guidance ...
  • Langan L, Baettig C, Cole A, Lovin L, Scarlett K, ...
  • Karle A, Kopp K, Seward R, Tourdot S, Ackaert C, ...
  • Bustin S, Kirvell S, Nolan T, Mueller R, Shipley G. ...
  • Jia Z, Liu Y, Qu S, Li W, Gao L, ...
  • Xia CL, Liang F, Li JX, Qu Y, Zhang W, ...
  • Lee C, Hyun S, Rhee I. Flow cytometric and multimodal ...
  • Wells SB, Rainbow DB, Mark M, Szabo PA, Ergen C, ...
  • Skill NJ, Avanzino K, Bren-Mattison Y, Boudreaux JP, Thiagarajan R, ...
  • Lei Y, Xiao T, Hu X, Lin H. Advanced drug ...
  • Behrens LMP, Fernandes G da S, Gonçalves GF, Nunes FVM, ...
  • Wang Q, Yuan F, Zuo X, Li M. Breakthroughs and ...
  • Xiao Y, Li Y, Jing X, Weng L, Liu X, ...
  • Zhao X, Gao J, Liu Y, Shi Y, Zhang M, ...
  • Bridgeford EW, Powell M, Kiar G, Noble S, Chung J, ...
  • Fang D, Min W. SpaCross deciphers spatial structures and corrects ...
  • Saadh M, Muhammad FA, Albadr RJ, Sanghvi G, Jyothi S, ...
  • Versnjak J, Kuehne T, Fahjen P, Jovanovic N, Loeber U, ...
  • Zhao YH, Cai YX, Pan ZY, Tang F, Chao, Wang ...
  • Hoy S. Mirdametinib: First approval. Drugs ۲۰۲۵; ۸۵: ۹۷۷-۹۸۴ ...
  • Munteanu I, Novaconi RC, Merce A, Dima C, Falnita L, ...
  • Tian H, Wan C. Comparative efficacy and safety of transarterial ...
  • Borji AH, Rahimi M, Alishvandi A, Barancheshmeh M, Aram C, ...
  • Lin K, Eyal S, Demarchi I, Ben-Shushan T, Auvin S, ...
  • Zhang J, Peng J, Yu C, Ning Y, Lin W, ...
  • Al-Rawashdeh TA, Al’azzeh F, Al-Tarawneh F. An analytical hierarchy process-based ...
  • Chen W, Zhi X, Hu J, Yu L, Han Q, ...
  • نمایش کامل مراجع